On October 21, 2025, Olympus Corporation, a global MedTech company dedicated to improving healthcare through innovation, announced the launch of THUNDERBEAT II, its next-generation hybrid surgical energy device designed for both laparoscopic and open soft tissue surgeries.
The device was introduced in the EMEA region and will become commercially available in Europe starting October 2025, with subsequent launches in Japan and other regions following regulatory approvals.
THUNDERBEAT II builds upon the legacy of Olympus’ THUNDERBEAT series, integrating ultrasonic and advanced bipolar energy to enable faster and more hemostatic dissection as well as secure large vessel transection. The newly designed probe and jaw structure have been refined to minimize thermal impact on surrounding tissues, providing enhanced precision and safety during complex surgical procedures.
The addition of a new ultrasonic energy mode offers surgeons greater versatility, allowing smooth transitions between different tissue types and surgical needs without changing instruments mid-procedure.
One of the key innovations in THUNDERBEAT II is its Thermal Shield Technology, which helps reduce unwanted heat transfer to surrounding tissues and vessels. This advancement aims to lower the risk of collateral thermal injury, a common concern in high-energy surgical devices.
The ergonomically engineered handle also improves surgeon comfort by reducing grip force requirements and offering tactile and audible feedback to confirm full closure of the jaws. Additionally, the device incorporates a cordless transducer design, repositioning the cable to the base of the handle to enhance maneuverability and reduce clutter in the operating field.
According to Olympus, THUNDERBEAT II’s combination of hybrid energy efficiency, refined ergonomics and enhanced safety represents a major step forward in surgical innovation. It is designed to support surgeons in performing complex procedures more efficiently, reducing operative time and potentially improving patient outcomes through precise energy delivery and minimal tissue trauma.
The launch underscores Olympus’ continued commitment to advancing surgical technologies that optimize clinical performance and safety. As hospitals and surgical centers evaluate adopting this new platform, considerations such as training, workflow adaptation and cost-effectiveness will play key roles in its integration into modern operating rooms.
Disclaimer: This article is intended for informational and educational purposes only. It does not constitute medical advice or product endorsement. Clinical use should comply with professional medical guidelines and local regulatory approvals.
